Hansoh Pharmaceutical (03692) Announces Adjustment of Conversion Price for Convertible Bonds from HK$59.33 to HK$58.13 per Share

Hansoh Pharma (03692) announced that, pursuant to the terms and conditions of the convertible bonds, the conversion price will be adjusted on the business day immediately following the record date for the payment of the final dividend for the year ended December 31, 2023. The conversion price will be adjusted from HK$59.33 per share to HK$58.13 per share, effective from June 26, 2024. Except for the adjustment to the conversion price, all other terms and conditions of the convertible bonds will remain unchanged.

As of the date of this announcement, the total outstanding principal amount of the convertible bonds is US$5.378 million. Upon conversion of all outstanding convertible bonds at the current conversion price and the adjusted conversion price, the maximum number of conversion shares to be issued will be 702,800 shares and 717,300 shares, respectively (based on a fixed exchange rate of HK$7.7529 to US$1.00).